About Us

Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

Our talent, scientific knowledge and research capabilities help us to deliver access to innovative, disease-altering therapies to those who need them most. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Celgene is headquartered in Summit, New Jersey, and employs more than 7,000 people located in more than 60 countries.

For more information, please visit the Company's website at www.celgene.com.

Life at Celgene

More than 2.3 million people around the world live with multiple sclerosis. Celgene is focused on continuing to advance research in multiple sclerosis. Our teams and an expert in the field share their excitement for what we’re doing now and what lies ahead for this complex disease and global community.

Patients Are Waiting – Celgene’s Personal Commitment to Pancreatic Cancer

Pancreatic cancer touches the lives of more people than you think, including some of our own. Our employees’ personal connections to pancreatic cancer give them the drive and passion needed in the fight against this disease. We are working every day to find solutions and to improve the lives of those affected by pancreatic cancer because we know #PatientsAreWaiting

Value of Medical Innovation

Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and our collective commitment. By working together, we can continue to fuel innovation and change patients’ lives.

About Celgene Corporation

Since its inception, Celgene Corporation has devoted itself to creating medications that improve the quality of life and prolong the life expectancy for people who suffer from chronic disease. The company conducts multiple clinical trials each year and has proved extraordinarily successful at obtaining FDA and EMA approval for its various products. – more... 

  • Celgene Corporation photo: Our Seattle location is dedicated to I/O research and patient data analysis
  • Celgene Corporation photo: Scientists discuss in the lab
  • Celgene Corporation photo: The Celgene Culture and Values
  • Celgene Corporation photo: The Annual Shareholder Meeting at Corporate Headquarters
Claimed Profile
Summit, New Jersey
$5B to $10B (USD)
5,001 to 10,000
Celgene Corporation website